Verified Nov 2026
Other
·
New York, New York
·
Since 1987
Delcath Systems, Inc. is a commercial-stage interventional oncology company headquartered in New York, New York, founded in 1987 and publicly traded on NASDAQ under the ticker DCTH. It has 100-200 employees and reported revenue in the $85.2M band. The company develops liver-directed cancer therapies for primary and metastatic liver cancers, including its HEPZATO KIT, which pairs melphalan with a proprietary Hepatic Delivery System, and serves the medical and healthcare sector.
Delcath Systems at a glance
Revenue
85.2M
Employees
100-200
Founded
1987
Headquarters
New York, New York
Ownership
Publicly traded (NASDAQ: DCTH)
Certifications
ISO 13485
Industries
Automotive
Electric Vehicles
Medical
STABILITY SIGNALS
Established & strong
39 years in operation (founded 1987).
Publicly listed; no distress event on record.
Holds ISO 13485 certification(s) per public sources.
Overview
Delcath Systems, Inc. is a commercial-stage interventional oncology company headquartered in New York, New York, founded in 1987 and publicly traded on NASDAQ under the ticker DCTH. It has 100-200 employees and reported revenue in the $85.2M band. The company develops liver-directed cancer therapies for primary and metastatic liver cancers, including its HEPZATO KIT, which pairs melphalan with a proprietary Hepatic Delivery System, and serves the medical and healthcare sector.
At a glance
Attribute | Detail |
|---|---|
Founded | 1987 |
Headquarters | New York, New York |
Employees | 100-200 |
Revenue | 85.2M |
Ownership | Publicly traded (NASDAQ: DCTH) |
Certifications | ISO 13485 |
What Delcath Systems makes
The company's products include the HEPZATO KIT, marketed for adult patients with metastatic uveal melanoma and unresectable hepatic metastases, and it holds ISO 13485 certification.
Certifications
Delcath Systems is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 13485 — prnewswire.com
Latest developments
2026-09-11 — Articles published by Delcath Systems, Inc. (wedbush.com)
2026-09-08 — News & Insights - Delcath (delcath.com)
2026-08-06 — Delcath Systems Reports Second Quarter 2026 Results and Business Highlights - Delcath Systems, Inc. (delcath.com)
2026-05-07 — Delcath Systems Reports First Quarter 2026 Results and Business Highlights - Delcath Systems, Inc. (delcath.com)
2026-02-26 — Delcath Systems Reports Fourth Quarter and Full Year 2025 Results - Delcath Systems, Inc. (delcath.com)
2025-11-04 — Delcath Systems Reports Third Quarter 2025 Results and Business Highlights - Delcath Systems, Inc. (delcath.com)
Company details
Delcath is publicly listed on NASDAQ and reports a portfolio of 28 patents related to its liver perfusion technologies. Delcath Systems was founded in 1987, has an estimated 100-200 employees, and is headquartered in New York, New York. On the LightSource stability read it is rated "Established & strong": 39 years in operation (founded 1987). Publicly listed; no distress event on record. Holds ISO 13485 certification(s) per public sources.
Frequently asked questions
What does Delcath Systems do?
Delcath Systems, Inc. is a commercial-stage interventional oncology company headquartered in New York, New York, founded in 1987 and publicly traded on NASDAQ under the ticker DCTH. It has 100-200 employees and reported revenue in the $85.2M band. The company develops liver-directed cancer therapies for primary and metastatic liver cancers, including its HEPZATO KIT, which pairs melphalan with a proprietary Hepatic Delivery System, and serves the medical and healthcare sector.
Where is Delcath Systems headquartered?
Delcath Systems is headquartered in New York, New York (1633 Broadway, New York, New York, 10019).
When was Delcath Systems founded?
Delcath Systems was founded in 1987.
How big is Delcath Systems?
Delcath Systems has an estimated 100-200 employees, with revenue in the 85.2M range.
Is Delcath Systems publicly traded?
Publicly traded (NASDAQ: DCTH). Public financial figures are drawn from its filings.
What certifications does Delcath Systems hold?
Delcath Systems lists ISO 13485 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.